Greg Fahy

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Gregory M. Fahy is a cryobiologist and biogerontologist, and is also Vice President and Chief Scientific Officer at Twenty-First Century Medicine, Inc. Fahy is the world's foremost expert in organ cryopreservation by vitrification.[1][2][3] Fahy introduced the modern successful approach to vitrification for cryopreservation in cryobiology[4][5][6][7][8][9][10][11] and he is widely credited, along with William F. Rall, for introducing vitrification into the field of reproductive biology.[7][12]

In the summer of 2005, where he was a keynote speaker at the annual Society for Cryobiology meeting, Fahy announced that Twenty-First Century Medicine had successfully cryopreserved a rabbit kidney at -130°C by vitrification and transplanted it into a rabbit after rewarming, with subsequent long-term life support by the vitrified-rewarmed kidney as the sole kidney. This research breakthrough was later published in the peer-reviewed journal Organogenesis.[3]

Fahy is also a well-known biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book on the future of biogerontology.[13] He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal and served for 16 years as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization's newsletter.

Previous research experience[edit]

Fahy has over thirty years of experience in the field of cryopreservation. As a scientist with the American Red Cross, he was the originator of the first practical method of cryopreservation by vitrification and the inventor of computer-based systems to apply this technology to whole organs. Before joining Twenty-First Century Medicine, he was the chief scientist for Organ, Inc and of LRT, Inc. He was also Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program of the U.S. Naval Medical Research Institute in Bethesda, Maryland where he spearheaded the original concept of ice blocking agents.

Education[edit]

A native of California, Fahy holds a Bachelor of Science degree in Biology from the University of California, Irvine and a Ph.D. in pharmacology from the Medical College of Georgia in Augusta.

He currently serves on the board of directors of two organizations, as a referee for numerous scientific journals and funding agencies, and holds nearly 30 patents on cryopreservation methods, aging interventions, transplantation, and other topics.

See also[edit]

References[edit]

  1. ^ Fahy GM, Wowk B, Wu J, Phan J, Rasch C, Chang A, Zendejas E. (2004). "Cryopreservation of organs by vitrification: perspectives and recent advances" (PDF). Cryobiology 48 (2): 157–178. doi:10.1016/j.cryobiol.2004.02.002. PMID 15094092. 
  2. ^ Fahy GM, Wowk B, Wu J. (2006). "Cryopreservation of complex systems: the missing link in the regenerative medicine supply chain" (PDF). Rejuvenation Research 9 (2): 279–291. doi:10.1089/rej.2006.9.279. PMID 16706656. 
  3. ^ a b Fahy GM, Wowk B, Pagotan R, Chang A, Phan J, Thomson B, Phan L (2009). "Physical and biological aspects of renal vitrification". ORGANOGENESIS 5 (3): 167–175. doi:10.4161/org.5.3.9974. PMC 2781097. PMID 20046680. 
  4. ^ Michael J. Taylor, Ying C. Song, and Kelvin G.M. Brockbank (2004). Vitrification in Tissue Preservation: New Developments In: Life in the Frozen State (B.J. Fuller, N. Lane, and E.E. Benson, Eds.). CRC Press. pp. 603–641. ISBN 0-415-24700-4. 
  5. ^ Fahy, G.M. and Hirsh, A. (1982). Prospects for Organ Preservation by Vitrification. In: Organ Preservation, Basic and Applied Aspects (D.E. Pegg, I.A. Jacobsen and N.A. Halasz, Eds.). Springer. pp. 399–404. ISBN 0-85200-418-4. 
  6. ^ Fahy GM, MacFarlane DR, Angell CA, Meryman HT (1984). "Vitrification as an approach to cryopreservation". Cryobiology 21 (4): 407–426. doi:10.1016/0011-2240(84)90079-8. PMID 6467964. 
  7. ^ a b Rall WF, Fahy GM (1985). "Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification". Nature (journal) 313 (6003): 573–575. doi:10.1038/313573a0. PMID 3969158. 
  8. ^ Fahy GM (1986). "Vitrification: a new approach to organ cryopreservation". PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH 224: 305–335. PMID 3540994. 
  9. ^ Fahy, Gregory M. (May 16, 2002). "Vitrification versus Freezing of Organs". Science (journal) E-Letter responses. American Association for the Advancement of Science. Retrieved 2010-10-22. 
  10. ^ Fahy, G.M., and Rall, W.F (2007). Vitrification: An overview. In: Vitrification in Assisted Reproduction: A User's Manual and Troubleshooting Guide (J. Liebermann and M.J. Tucker, Eds). Informa Healthcare. ISBN 0-415-40882-2. 
  11. ^ Mullen, S.F., and Fahy, G.M (February 28, 2011). Fundamental aspects of vitrification as a method of reproductive cell, tissue, and organ cryopreservation. In: Principles & Practice of Fertility Preservation (Donnez, J., and Kim, S.S., Eds.). Cambridge University Press. ISBN 0-521-19695-7. 
  12. ^ "Cryopreservation of embryos". The Lancet 1 (8430): 678. 1985. doi:10.1016/s0140-6736(85)91336-4. PMID 2858625. 
  13. ^ Gregory M. Fahy, Michael D. West, L. Stephen Coles, and Steven B. Harris, ed. (October 2010). The Future of Aging: Pathways to Human Life Extension. Springer. ISBN 90-481-3998-8. 

External links[edit]